The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence.

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence.,, ...
Medical Device and Diagnostic Industry (MD+DI)

FDA Approves Johnson & Johnson's Breakthrough Cataracts Solution

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...
Healio

FDA approves Johnson & Johnson’s Tecnis PureSee IOL

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...
News Medical

Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan ...
PharmiWeb

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients

TECNIS PureSee IOL197% of patients would recommend this IOL to friends or family2TECNIS PureSee IOL is the first and only U.S. FDA-approved extended depth of focus (EDOF) IOL maintaining contrast ...
GlobalData on MSN

FDA approves J&J’s TECNIS PureSee intraocular lens

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

Johnson & Johnson launches next-gen intraocular lens in India

Johnson & Johnson introduces the TECNIS Odyssey IOL in India, enhancing vision for cataract patients with advanced technology.